Does prophylactic breast irradiation prevent antiandrogen-induced gynecomastia? Evaluation of 253 patients in the randomized Scandinavian trial SPCG-7/SFUO-3. Widmark A, Fossa SD, Lundmo P, Damber JE, Vaage S, Damber L, Wiklund F, Klepp O, Department of Oncology, Umea University, Umea, Sweden - Urology 2003;61:145-151

Author： Trump D.L.  

Publisher： Elsevier

ISSN： 1078-1439

Source： Urologic Oncology: Seminars and Original Investigations, Vol.21, Iss.5, 2003-09, pp. : 407-407

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma. Saad F, Gleason DM, Murray R, Tchekmedyian S, Venner P, Lacombe L, Chin JL, Vinholes JJ, Goas JA, Chen B, Zoledronic Acid Prostate Cancer Study Group, Uro-Oncology Clinic, Centre Hospitalier de l'Universite, de Montreal, Hopital Notre-Dame, Montreal, Quebec, Canada - J Natl Cancer Inst 2002;94:1458-1468

By Trump D.L.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 5, 2003-09 ,pp. : 408-408

Elsevier

Access to resources Recommend Favorite

Multimodal exercise improves quality of life of women being treated for breast cancer, but at what cost? Randomized trial with economic evaluation

By Haines Terry  

Breast Cancer Research and Treatment, Vol. 124, Iss. 1, 2010-11 ,pp. : 163-175

Springer Publishing Company

Access to resources Recommend Favorite

Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): a phase 2, multicenter, randomized, double-blind, placebo-controlled trial of goshajinkigan to prevent oxaliplatin-induced neuropathy

By Kono Toru   Hata Taishi   Morita Satoshi   Munemoto Yoshinori   Matsui Takanori   Kojima Hiroshi   Takemoto Hiroyoshi   Fukunaga Mutsumi   Nagata Naoki   Shimada Mitsuo   Sakamoto Junichi   Mishima Hideyuki  

Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 6, 2013-12 ,pp. : 1283-1290

Springer Publishing Company

Access to resources Recommend Favorite

Pentoxifylline in prevention of radiation-induced lung toxicity in patients with breast and lung cancer: a double-blind randomized trial

By Ozturk B.   Egehan I.   Atavci S.   Kitapci M.  

International Journal of Radiation Oncology*Biology*Physics, Vol. 58, Iss. 1, 2004-01 ,pp. : 213-219

Elsevier

Access to resources Recommend Favorite

Prognostic significance of RACGAP1 mRNA expression in high-risk early breast cancer: a study in primary tumors of breast cancer patients participating in a randomized Hellenic Cooperative Oncology Group trial

By Pliarchopoulou K.   Kalogeras K.   Kronenwett R.   Wirtz R.   Eleftheraki A.   Batistatou A.   Bobos M.   Soupos N.   Polychronidou G.   Gogas H.   Samantas E.   Christodoulou C.   Makatsoris T.   Pavlidis N.   Pectasides D.   Fountzilas G.  

Cancer Chemotherapy and Pharmacology, Vol. 71, Iss. 1, 2013-01 ,pp. : 245-255

Springer Publishing Company

Access to resources Recommend Favorite